<code id='69D944F53E'></code><style id='69D944F53E'></style>
    • <acronym id='69D944F53E'></acronym>
      <center id='69D944F53E'><center id='69D944F53E'><tfoot id='69D944F53E'></tfoot></center><abbr id='69D944F53E'><dir id='69D944F53E'><tfoot id='69D944F53E'></tfoot><noframes id='69D944F53E'>

    • <optgroup id='69D944F53E'><strike id='69D944F53E'><sup id='69D944F53E'></sup></strike><code id='69D944F53E'></code></optgroup>
        1. <b id='69D944F53E'><label id='69D944F53E'><select id='69D944F53E'><dt id='69D944F53E'><span id='69D944F53E'></span></dt></select></label></b><u id='69D944F53E'></u>
          <i id='69D944F53E'><strike id='69D944F53E'><tt id='69D944F53E'><pre id='69D944F53E'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:1
          A pair of scissor cuts four paper figures from a line of them — biotech coverage from STAT
          Adobe

          Sonata Therapeutics, a startup created two years ago through the merger of two Flagship Pioneering companies, has laid off about a third of its staff.

          The biotech laid off 21 employees in recent weeks, according to employee posts on social media and a company spokesperson. Sonata had around 63 employees before the layoffs.

          advertisement

          Sonata is just the latest in a series of startups laying off employees in order to stretch out their cash runways. Privately held startups have had a difficult time raising money during the recent biotech downturn, which has shown signs of abating in the last few months. But at this point, startups are still finding that private investors and venture capitalists are being cautious with their money as they wait to see if the downturn is truly over.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more
          European regulators consider appeal over Amylyx ALS drug
          European regulators consider appeal over Amylyx ALS drug

          PauloAmorim/VWPicsviaAPImagesLONDON—Thisweek,EuropeanregulatorsareconsideringanappealfromAmylyxPharm

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          A fraught question for the kids of Alzheimer’s: Is it coming for us?

          Mysisterhasafantasyaboutouroldage:Sheimaginesthatthesevensiblingsinourfamilywillbelivingtogetheragai